EP 1212047 A2 20020612 - USE OF CHARGED DEXTRAN AS A MUCOACTIVE AGENT AND METHODS AND PHARMACEUTICAL COMPOSITIONS RELATING THERETO
Title (en)
USE OF CHARGED DEXTRAN AS A MUCOACTIVE AGENT AND METHODS AND PHARMACEUTICAL COMPOSITIONS RELATING THERETO
Title (de)
VERWENDUNG VON GELADENEM DEXTRAN ALS MUKOAKTIVES MITTEL UND METHODEN SOWIE DAMIT VERBUNDENE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Title (fr)
UTILISATION DE DEXTRANE COMME AGENT MUCOACTIF, METHODES ET COMPOSITIONS PHARMACEUTIQUES CONNEXES
Publication
Application
Priority
- CA 0000989 W 20000825
- US 15060599 P 19990826
Abstract (en)
[origin: WO0115672A2] The present invention is for a charged dextran, preferably dextran sulfate, as an improved mucoactive agent which can be used to improve viscoelasticity and clearance of respiratory tract mucus. The charged dextran can be used in the treatment of animals with impaired mucus clearance, mucus retention and/or mucus hypersecretion, such as cystic fibrosis, chronic bronchitis, bronchiectasis, bronchiolitis and bronchial asthma. Related methods of treatment and pharmaceutical compositions, particularly aerosolized dextran sulfate compositions are encompassed within the scope of the invention.
IPC 1-7
IPC 8 full level
A61K 31/721 (2006.01)
CPC (source: EP)
A61K 31/721 (2013.01); A61P 11/12 (2017.12)
Citation (search report)
See references of WO 0115672A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0115672 A2 20010308; WO 0115672 A3 20020228; AU 6679300 A 20010326; CA 2382259 A1 20010308; EP 1212047 A2 20020612; HK 1047246 A1 20030214
DOCDB simple family (application)
CA 0000989 W 20000825; AU 6679300 A 20000825; CA 2382259 A 20000825; EP 00954242 A 20000825; HK 02108959 A 20021211